Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of β-lactam resistance in Enterobacteriaceae derived from blood cultures

Journal of Clinical Microbiology

Volumn 52, Issue 3, 2014, Pages 924-930

  Jung, Jette Sophia ^a   Popp, Christina ^b   Sparbier, Katrin ^c   Lange, Christoph ^c   Kostrzewa, Markus ^c   Schubert, Soeren ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c BRUKER DALTONIK GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; BETA LACTAMASE; BETA LACTAMASE CLASS A; BETA LACTAMASE CLASS C; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BLOOD CULTURE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; EVALUATION RESEARCH; FALSE POSITIVE RESULT; GRAM STAINING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REACTION TIME; SENSITIVITY AND SPECIFICITY; STRAIN IDENTIFICATION;

BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMS; BLOOD; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84894589318     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02691-13     Document Type: Article

References (28)

1. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. 2006. Sepsis in European intensive care units: results of the SOAP study. Crit. Care. Med. 34:344- 353. http://dx.doi.org/10. 1097/01.CCM.0000194725.48928.3A. (Pubitemid 43145611)
2. Schwaber MJ, Carmeli Y. 2007. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60:913-920. http://dx.doi.org/10.1093/jac/dkm318. (Pubitemid 47617735)
3. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Simon D, Peters C, Ahsan M, Chateau D. 2009. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:1237-1248. http://dx.doi.org/doi: 10.1378/chest.09-0087.
4. Beekmann SE, Diekema DJ, Chapin KC, Doern GV. 2003. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J. Clin. Microbiol. 41:3119-3125. http://dx.doi.org/10 .1128/JCM.41.7.3119-3125.2003. (Pubitemid 36842309)
5. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. 2005. Bloodstream infections caused by antibiotic-resistant gramnegative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob. Agents Chemother. 49:760-766. http://dx.doi.org/10. 1128/AAC.49.2.760-766.2005.
6. Kumar A. 2011. Optimizing antimicrobial therapy in sepsis and septic shock. Crit. Care Nurs. Clin. North. Am. 23:79-97. http://dx.doi.org/10 .1016/j.ccell.2010.12.005.
7. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. 2008. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 36: 296-327. http://dx.doi.org/10.1097/01.CCM. 0000298158.12101.41.
8. Leone M, Martin C. 2008. How to break the vicious circle of antibiotic resistances? Curr. Opin. Crit. Care. 14:587-592. http://dx.doi.org/10.1097 /MCC.0b013e32830f1deb.
9. Clerc O, Prod'hom G, Vogne C, Bizzini A, Calandra T, Greub G. 2013. Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clin. Infect. Dis. 56:1101- 1107. http://dx.doi.org/10.1093/cid/cis1204.
10. Schubert S, Weinert K, Wagner C, Gunzl B, Wieser A, Maier T, Kostrzewa M. 2011. Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix-assisted laser desorption/ ionization time-of-flight (MALDI-TOF) mass spectrometry. J. Mol. Diagn. 13:701-706. http://dx.doi.org/10.1016/j.jmoldx.2011.07.004.
11. Wüppenhorst N, Consoir C, Lorch D, Schneider C. 2012. Direct identification of bacteria from charcoal-containing blood culture bottles using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. Eur. J. Clin. Microbiol. Infect. Dis. 31:2843-2850. http://dx.doi.org/10.1007/ s10096-012-1638-2.
12. Livermore DM. 2012. Current epidemiology and growing resistance of gram-negative pathogens. Korean J. Intern. Med. 27:128-142. http://dx.doi.org/ 10.3904/kjim.2012.27.2.128.
13. Paterson DL. 2006. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control 34:S20 -S28; discussion S64 -S73. http://dx.doi.org/10.1016/j.ajic.2006.05.238.
14. Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M. 2012. Matrix-assisted laser desorption ionization-time of flight mass spectrometry- based functional assay for rapid detection of resistance against betalactam antibiotics. J. Clin. Microbiol. 50:927-937. http://dx.doi.org/10.1128/JCM. 05737-11.
15. Hrabák J, Študentová V, Walková R, Žemličková H, Jakubu V, Chudáčková E, Gniadkowski M, Pfeifer Y, Perry JD, Wilkinson K, Bergerová T. 2012. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionizationtime of flight mass spectrometry. J. Clin. Microbiol. 50:2441-2443. http: //dx.doi.org/10.1128/JCM.01002-12.
16. Hrabák J, Walková R, Študentová V, Chudáčková E, Bergerova T. 2011. Carbapenemase activity detection by matrix-assisted laser desorption ionization- time of flight mass spectrometry. J. Clin. Microbiol. 49:3222- 3227. http://dx.doi.org/10.1128/JCM. 00984-11.
17. Burckhardt I, Zimmermann S. 2011. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J. Clin. Microbiol. 49:3321-3324. http: //dx.doi.org/10.1128/JCM.00287-11.
18. Bonnedahl J, Drobni P, Johansson A, Hernandez J, Melhus A, Stedt J, Olsen B, Drobni M. 2010. Characterization, and comparison, of human clinical and black-headed gull (Larus ridibundus) extended-spectrum beta- lactamase-producing bacterial isolates from Kalmar, on the southeast coast of Sweden. J. Antimicrob. Chemother. 65:1939-1944. http://dx.doi.org/10.1093/jac/dkq222.
19. R Core Team. 2013. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
20. Gibb S, Strimmer K. 2012. MALDIquant: a versatile R package for the analysis of mass spectrometry data. Bioinformatics 28:2270-2271. http: //dx.doi.org/10.1093/bioinformatics/bts447.
21. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; 23rd informational supplemental. CLSI M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
22. Kumar A, Schweizer H. 2005. Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv. Drug Deliv. Rev. 57:1486-1513. http://dx.doi.org/10.1016/j.addr.2005.04.004. (Pubitemid 40984603)
23. Li XZ, Ma D, Livermore DM, Nikaido H. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance. Antimicrob. Agents Chemother. 38:1742-1752. http://dx.doi.org/10.1128/AAC.38.8.1742. (Pubitemid 24250719)
24. Stürenburg E, Mack D. 2003. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J. Infect. 47:273-295. http://dx.doi.org/10.1016/S0163-4453(03)00096-3. (Pubitemid 37322047)
25. MacKenzie FM, Miller CA, Gould IM. 2002. Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection. Clin. Microbiol. Infect. 8:715-724. http://dx.doi.org/10.1046/j.1469-0691.2002.00473. x. (Pubitemid 35385868)
26. Piddock LJ. 2006. Multidrug-resistance efflux pumps-not just for resistance. Nat. Rev. Microbiol. 4:629 - 636. http://dx.doi.org/10.1038/ nrmicro1464. (Pubitemid 44317025)
27. Piddock LJ. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19:382-402. http://dx.doi.org/10.1128/CMR.19.2.382-402.2006.
28. Livermore DM. 1988. Permeation of beta-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other gram-negative bacteria. Rev. Infect. Dis. 10:691-698. http://dx.doi.org/10.1093/clinids/10.4.691.